BNP Paribas Financial Markets Invests $876,000 in LifeStance Health Group, Inc. (NASDAQ:LFST)

BNP Paribas Financial Markets purchased a new stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund purchased 118,842 shares of the company's stock, valued at approximately $876,000.

Other hedge funds have also added to or reduced their stakes in the company. Ameriprise Financial Inc. bought a new position in shares of LifeStance Health Group in the fourth quarter valued at approximately $87,000. Northern Trust Corp raised its position in LifeStance Health Group by 11.7% in the 4th quarter. Northern Trust Corp now owns 1,591,776 shares of the company's stock valued at $11,731,000 after buying an additional 166,731 shares during the last quarter. Susquehanna Fundamental Investments LLC bought a new position in LifeStance Health Group during the 4th quarter valued at $1,377,000. Price T Rowe Associates Inc. MD boosted its holdings in LifeStance Health Group by 15.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 66,855 shares of the company's stock worth $493,000 after acquiring an additional 9,009 shares during the last quarter. Finally, Dark Forest Capital Management LP boosted its holdings in LifeStance Health Group by 371.6% during the 4th quarter. Dark Forest Capital Management LP now owns 48,497 shares of the company's stock worth $357,000 after acquiring an additional 38,213 shares during the last quarter. Institutional investors and hedge funds own 85.50% of the company's stock.

LifeStance Health Group Price Performance

NASDAQ:LFST traded up $0.57 during mid-day trading on Tuesday, hitting $6.06. 3,797,645 shares of the stock traded hands, compared to its average volume of 1,589,747. The business's 50-day moving average price is $6.37 and its 200 day moving average price is $7.15. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19. The company has a market cap of $2.36 billion, a PE ratio of -23.31 and a beta of 1.30. LifeStance Health Group, Inc. has a 12-month low of $4.64 and a 12-month high of $8.61.

Analyst Ratings Changes

A number of research analysts recently weighed in on the stock. Canaccord Genuity Group started coverage on shares of LifeStance Health Group in a research report on Thursday, April 3rd. They set a "buy" rating and a $8.00 price target on the stock. William Blair reiterated an "outperform" rating on shares of LifeStance Health Group in a research note on Friday, February 28th. UBS Group upgraded shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 target price for the company in a research note on Tuesday. Finally, KeyCorp initiated coverage on LifeStance Health Group in a report on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 price target for the company. One equities research analyst has rated the stock with a sell rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, LifeStance Health Group currently has a consensus rating of "Moderate Buy" and an average price target of $8.50.

Insider Buying and Selling at LifeStance Health Group

In other news, insider Lisa K. Miller sold 18,845 shares of the company's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the transaction, the insider now owns 339,810 shares of the company's stock, valued at approximately $2,344,689. This represents a 5.25% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 3.20% of the company's stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.